Personal information

Activities

Works (6)

Erken Evre Küçük Hücreli Dışı Akciğer Kanserinde Neoadjuvan Tedavilerin Etkinliği: Tek Merkez Deneyimi

Uludağ Üniversitesi Tıp Fakültesi Dergisi
2025-01-12 | Journal article
Contributors: Yasin Kutlu; Ahmet Bilici; Ömer Ölmez; Jamshid Hamdard; Ebru Karcı; Özgür Açıkgöz
Source: check_circle
Crossref

Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer

Current Problems in Cancer
2024-06 | Journal article
Contributors: Yasin Kutlu; Ruhper Cekin; Sabin Goktas Aydin; Abdallah T M Shbair; Ahmet Bilici; Serdar Arici; Bala Basak Oven; Ozgur Acikgoz; Erkan Ozcan; Omer Fatih Olmez et al.
Source: check_circle
Crossref

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study

Cancers
2024-06 | Journal article | Author
Contributors: Yasin Kutlu; Shute Ailia Dae; Feride Yilmaz; Dilek Erdem; Mehmet Ali Nahit Sendur; Sinem Akbas; Elif Senocak Tasci; Onur Bas; Faysal Dane; Abdullah SAKİN et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Erken Evre Triple Negatif Meme Kanserinde Sağkalım Sonuçları ve Prognostik Faktörler: Tek Merkez Deneyimi

Uludağ Üniversitesi Tıp Fakültesi Dergisi
2023-12-31 | Journal article
Contributors: Yasin KUTLU; Sabin GOKTAS AYDIN; Ahmet BİLİCİ; Ömer ÖLMEZ; Ozgur ACİKGOZ; Jamshid HAMDARD; Özcan YILDIZ; Ebru KARCI; Harun MUĞLU
Source: check_circle
Crossref

Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer

International Immunopharmacology
2023-11 | Journal article
Contributors: Sabin Goktas Aydin; Ahmet Bilici; Elif Calis; Yasin Kutlu; Jamshid Hamdard; Harun Muglu; Omer Fatih Olmez; Ebru Karci; Ozgur Acikgoz
Source: check_circle
Crossref

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy

Medicine
2023-04-14 | Journal article
Contributors: Yasin Kutlu; Sabin Goktas Aydin; Ahmet Bilici; Bala Basak Oven; Omer Fatih Olmez; Ozgur Acikgoz; Jamshid Hamdard
Source: check_circle
Crossref